MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2023-24)
- Udyam number
- UDYAM-KL-02-0039235
Blackbryont Pharmaceuticals Private Limited - pharma in Ernakulam, Kerala, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹1.57 Cr
▼ 3% YoY
Net profit · FY 2025
₹10,378
Net margin 0.1%
EBITDA · FY 2025
₹8.78 Lakh
EBITDA margin 5.6%
Authorised capital
₹30 Lakh
Registered with MCA
Paid-up capital
₹26 Lakh
Issued & subscribed
Open charges
₹39.07 Lakh
Satisfied ₹35 Lakh
Company age
17 yrs
Est. 2009
Directors on board
7
As per MCA filings
About Blackbryont Pharmaceuticals Private Limited
Data last updated:
Blackbryont Pharmaceuticals Private Limited is a private limited company based in Ernakulam, Kerala, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 30 September 2009 and has been in existence for over 17 years.
The company is registered with the Registrar of Companies (ROC), Ernakulam, under CIN U24232KL2009PTC024806. Its GSTIN is 32AAECB2515J1Z3 (Kerala).
The company has an authorised share capital of ₹30 Lakh and a paid-up capital of ₹26 Lakh. It is led by directors including Jayagopal Narayanan (Managing Director) and Sugunan Mathilakath.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at No.38/905 – A(Old 34/1131 – A1) Balakrishna Menon Road Edappally.P.O . Cochin – 682024, Ernakulam, Kerala, India – 682024.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.57 Cr, a decline of 3% compared to the previous year. For the same year it recorded a net profit of ₹10,378 (net margin 0.1%) and EBITDA of ₹8.78 Lakh (EBITDA margin 5.6%). Revenue has grown at a compounded annual rate (CAGR) of 10% over three years and 6% over five years.
The company is associated with 1 brand: Black Bryont Pharmaceuticals. As per MCA filings, the company has open charges of ₹39.07 Lakh and satisfied charges of ₹35 Lakh on record.
Blackbryont Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-KL-02-0039235). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website blackbryont.com.
Company details
CIN U24232KL2009PTC024806
Registration Number 024806
Incorporation Date 30 September 2009
ROC Ernakulam
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-KL-02-0039235
Key People
Jayagopal Narayanan Managing Director Sivasankara Menon Biju Additional Director Sugunan Mathilakath Director Recognitions & Rankings of Blackbryont Pharmaceuticals
Contact details
Blackbryont Pharmaceuticals Private Limited's registered office is in Ernakulam, Kerala. Its website is blackbryont.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressNo.38/905 – A(Old 34/1131 – A1) Balakrishna Menon Road Edappally.P.O . Cochin – 682024, Ernakulam, Kerala, India – 682024
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Blackbryont Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Blackbryont Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Blackbryont Pharmaceuticals operates one associated brand: Black Bryont Pharmaceuticals. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Provision of pharmaceuticals and medical services in India. | blackbryont.com |
Business activity
The main business activity of Blackbryont Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Blackbryont Pharmaceuticals Private Limited, buy the company report.
Financials of Blackbryont Pharmaceuticals Private Limited
FY 2025 filings availableBlackbryont Pharmaceuticals Private Limited reported revenue of ₹1.57 Cr (down 3% YoY) for FY 2025.
Revenue · FY 2025
₹1.57 Cr ▼ 3%
Net profit · FY 2025
₹10,378 margin 0.1%
EBITDA · FY 2025
₹8.78 Lakh margin 5.6%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 3%
3 years · compounded
▲ 10%
5 years · compounded
▲ 6%
EBITDA CAGR growth
1 year
▲ 1%
3 years · compounded
▼ 7%
5 years · compounded
▲ 1%
Revenue fell 3% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 6%. EBITDA rose 1% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹8.78 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹10,378 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.6% | ||||
| Net Profit Margin | 0.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Blackbryont Pharmaceuticals Private Limited, buy the company report.
Board of directors of Blackbryont Pharmaceuticals Private Limited
Blackbryont Pharmaceuticals has 7 current directors and 9 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sivasankara Menon Biju | Additional Director | 01 Jun 2014 | 12 Years 4 Months | Current |
| Sugunan Mathilakath | Director | 30 Sep 2009 | 17 Years 0 Months | Current |
| Ravindran Thekkedath | Director | 30 Sep 2009 | 17 Years 0 Months | Current |
| Sivadas Gopi | Director | 13 Dec 2017 | 8 Years 10 Months | Current |
| Shibu Kurian | Additional Director | 01 Apr 2013 | 13 Years 6 Months | Current |
| Manoj Valiya Parakkatt | Director | 13 Dec 2017 | 8 Years 10 Months | Current |
Showing 6 of 7 current directors. View all directors
Auditor
Blackbryont Pharmaceuticals Private Limited is audited by PRABHU HEGDE & ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| PRABHU HEGDE & ASSOCIATES | FY 2023 | 012225S |
Shareholding
The shareholding of Blackbryont Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Blackbryont Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹39.07 Lakh
Satisfied charges
₹35 Lakh
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 27 Jun 2024 | 100967039 | Others | ₹32 Lakh | Open | |
| 03 Mar 2021 | 100455785 | Hdfc Bank Limited | ₹7.07 Lakh | Open | |
| 20 Oct 2020 | 100398980 | Uco Bank | ₹35 Lakh | Satisfied |
To see the full charge records of Blackbryont Pharmaceuticals Private Limited, buy the company report.
Total charge records: 3 View all charges
Legal cases
No court or tribunal cases involving Blackbryont Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Blackbryont Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Blackbryont Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 32AAECB2515J1Z3 | Kerala | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Blackbryont Pharmaceuticals Private Limited, buy the company report.
Recent activity
Blackbryont Pharmaceuticals Private Limited has 16 board changes on record since 2009: 7 appointments and 9 cessations. The latest: Rajananda Govindaraj ceased to be Director on 31 Dec 2019.
AGM
Blackbryont Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Blackbryont Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ernakulam.
Charges
A charge registered on 20 Oct 2020 via Charge ID 100398980 with Uco Bank was fully satisfied on 13 Aug 2024.
Charges
A charge with Others amounted to Rs. 32.00 Lakh with Charge ID 100967039 was registered on 27 Jun 2024.
Charges
A charge with Uco Bank of Rs. 35.00 Lakh registered on 20 Oct 2020 with Charge ID 100398980 was modified on 20 Jan 2024.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 7.07 Lakh with Charge ID 100455785 was registered on 03 Mar 2021.
Charges
A charge with Uco Bank amounted to Rs. 35.00 Lakh with Charge ID 100398980 was registered on 20 Oct 2020.
Ceased
Rajananda Govindaraj ceased to be Director.
Ceased
Arun Kumar Patarmadathilunikat ceased to be Director.
Ceased
Shajeem ceased to be Director.
Ceased
Manoj Valiya Parakkatt ceased to be Additional Director.
Ceased
Sivadas Gopi ceased to be Additional Director.
12 earlier events are in the company report.
Frequently asked questions
Blackbryont Pharmaceuticals is an active private limited company based in Ernakulam, Kerala, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 30 September 2009 (17+ years old) and is registered under CIN U24232KL2009PTC024806.
Blackbryont Pharmaceuticals has 7 current directors:
- Jayagopal Narayanan - Managing Director
- Sivasankara Menon Biju - Additional Director
- Sugunan Mathilakath - Director
- Ravindran Thekkedath - Director
- Sivadas Gopi - Director
- Shibu Kurian - Additional Director
- Manoj Valiya Parakkatt - Director
The latest financial statements of Blackbryont Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Blackbryont Pharmaceuticals is 32AAECB2515J1Z3, registered in Kerala.
The CIN (Corporate Identification Number) of Blackbryont Pharmaceuticals is U24232KL2009PTC024806. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Blackbryont Pharmaceuticals was incorporated on 30 September 2009, making it 17+ years old. It is registered with the Registrar of Companies, Ernakulam.
Rajananda Govindaraj ceased to be Director on 31 Dec 2019. Arun Kumar Patarmadathilunikat ceased to be Director on 10 Apr 2019. Shajeem ceased to be Director on 10 Apr 2019. Blackbryont Pharmaceuticals has 16 board changes on record in total.
Yes, Blackbryont Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-KL-02-0039235).
Blackbryont Pharmaceuticals can be reached through the website blackbryont.com. Its registered office is in Ernakulam, Kerala, India.
The registered office of Blackbryont Pharmaceuticals is at No.38905 – AOld 341131 – A1 Balakrishna Menon Road Edappally.P.O . Cochin – 682024, Ernakulam, Kerala, India – 682024.